Company / Profit Margin
Abbott Laboratories Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
14.7%
FY2025
5-year range
11.6% / 31.9%
FY2021-FY2025
Trend
-53.9%
vs FY2024
Sector context
#22 of 156
Health Care
What the data says
Abbott Laboratories's profit margin of 14.7% is higher than 86% of companies in the Health Care sector (FY2025). Profit Margin has fluctuated over the past 10 years, ranging from 6.7% in FY2018 to 31.9% in FY2024.
Based on SEC 10-K filings.
14.7% in FY2025 with a 5-year CAGR of +7.0%. Top quartile in the Health Care sector.
Declined from 16.4% to 14.7% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +1.7pp
- 5-Year Change
- +7.0pp
- 10-Year Change
- -
Sector benchmark
Top 14% in Health CareTop 14% of 156This company 14.7% Sector average -252.5%
▼
+105.8% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 53.9% year-over-year.
- Currently 267.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2024.
- Lowest profit margin in the period was in FY2018.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 14.7% | -53.9% |
| FY2024 | 31.9% | +94.6% |
| FY2023 | 16.4% | +26.4% |
| FY2022 | 13.0% | +12.4% |
| FY2021 | 11.6% | +49.4% |
| FY2020 | 7.7% | -33.0% |
| FY2019 | 11.6% | +72.3% |
| FY2018 | 6.7% | -69.0% |
| FY2017 | 21.7% | +92.2% |
| FY2016 | 11.3% | -13.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026